DYVOXNasdaq StockholmTechnologyIFRS · SEK

Dynavox Group

Dynavox Group specializes in developing and selling assistive communication solutions aimed at enhancing the lives of individuals with disabilities. The company focuses on creating computer software and hardware that support communication for people with various disabilities, including autism. With a strong emphasis on innovation, Dynavox Group has shown significant growth in both revenue and profit, driven by new product launches and strategic acquisitions. The company is committed to raising awareness about assistive communication to drive future growth and community impact.

Revenue2,467m SEK
+25.1 %y/y
Operating profit (EBIT)254m SEK
+11.2 %y/y
EBIT margin10.3%
−1.3 ppy/y
Net income166m SEK
+13.6 %y/y
Free cash flow-8.0m SEK
−103.6 %y/y

Fiscal year 2025 · change from previous year

Development 2021–2025

05001,0001,5002,0002,500m SEK2021: 872 m SEK2021: EBIT 60 m SEK20212022: 1,216 m SEK2022: EBIT 82 m SEK20222023: 1,613 m SEK2023: EBIT 155 m SEK20232024: 1,972 m SEK2024: EBIT 229 m SEK20242025: 2,467 m SEK2025: EBIT 254 m SEK20252,467254
RevenueOperating profit (EBIT)

Business

Share of revenue
Assistive Communication Software40 %

Includes software solutions for communication aids

Hardware Solutions30 %

Comprises computer-related hardware for assistive communication

Custom Devices20 %

Customizable devices tailored for individual communication needs

Services10 %

Training and support services for product users

Customers

Dynavox Group's customer base includes individuals with disabilities, healthcare providers, educational institutions, and caregivers. The company's products are particularly popular among children and young people with autism, who benefit from symbol-based touch solutions. Healthcare providers and educational institutions use Dynavox's solutions to support communication for individuals with speech and language impairments. Caregivers and families also rely on these products to enhance the quality of life for their loved ones.

Individuals with Disabilities

Purchase communication aids for personal use

Healthcare Providers

Integrate assistive technology into patient care

Educational Institutions

Support students with special needs

Caregivers and Families

Enhance communication for loved ones

Strategy

Dynavox Group's strategic priorities focus on expanding market penetration and enhancing product offerings. The company aims to raise awareness about assistive communication solutions to drive growth. Strategic acquisitions, such as the recent purchase of Link Assistive, are key to expanding geographic reach and customer base. Investments in sales capacity and internal systems are intended to improve scalability and operational efficiency, supporting long-term margin improvement goals.

Expand market penetrationMedium term

To increase awareness and adoption of assistive solutions

Strategic acquisitionsShort term

To enter new markets and enhance customer base

Improve scalabilityLong term

To support growth and operational efficiency

Geography

Dynavox Group operates globally, with significant market presence in North America and Europe. The company has recently expanded its reach in the Australian and New Zealand markets through strategic acquisitions. This geographic diversification helps mitigate risks associated with regional economic fluctuations and regulatory changes. The company's global presence allows it to tap into diverse markets and cater to a wide range of customer needs.

Risks

Dynavox Group faces several business risks, including economic climate fluctuations, competitive pressures, and currency risks. Regulatory risks are significant, particularly in the U.S. where the company is under FDA supervision. The risk of impairment write-downs of capitalized R&D and other intangible assets is also present. Additionally, the company must navigate credit risks related to customer financing and potential financing risks.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Impairment write-downs1Regulatory risks2Currency risks3
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Impairment write-downsImpact: HighLikelihood: High

    Capitalized R&D and intangible assets

  2. Regulatory risksImpact: HighLikelihood: Low

    FDA supervision in the U.S.

  3. Currency risksImpact: MediumLikelihood: Low

    Impact on international operations

Accounting

Judgemental items
Revenue recognition

Affects timing and comparability of financial results

Share-based payments

Dilutive effect on earnings per share

Impairment write-downs

Potential impact on financial statements

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026